Jump to navigation Sign in to your account Language Flag Enter your keywords <non> Products & services Product browser Quality Regulatory product documents Resource Center Background articles Biomarkers: β-amyloid and tau Biomarker: HBcrAg Biomarker: HE4 Biomarker: KL-6 Biomarker: Mesothelioma Biomarker: Pepsinogen Biomarker: PIVKA-II Support Frequently Asked Questions Regulatory / Quality documents Safety Data Sheets Certificates of Analysis CE Declarations of Conformity Assigned Value Sheets IFUs / Package Inserts Automated Test Procedures ISO and GMP Certificates Order Handling Conditions of sale Fujirebio Europe distributor extranet Careers Why work at Fujirebio? Job offers Spontaneous application News & Events News Events Sign up for our newsletter Contact Let's stay in touch Follow us on LinkedIn Sign up for our newsletter Customer satisfaction survey How to contact us Find your local contact Fujirebio Europe (Belgium) Fujirebio Diagnostics (Sweden) Data Privacy EuroMedLab 2017 Make Excellence Routine EuroMedlab 2017 in Athens, Greece featured an educational workshop during which three eminent speakers, Profs. M. Plebani (Italy), E. Cavalier (Belgium) and K. Blennow (Sweden), reviewed three recently launched fully automated Lumipulse® G assays. Read more Vitamina D Innovación en el ensayo de Vitamina D Lumipulse® G 25-OH Vitamin D es un equipo de cartuchos de inmunoreacción para diagnóstico in vitro (IVD) para la determinación cuantitativa de 25-hidroxi vitamina D (25-OH-D) en suero o plasma humano para evaluar los niveles de vitamina D. VITAMINA D Nuovo “raggio di luce” nella diagnostica della vitamina D Il kit Lumipulse® G 25-OH Vitamin D, per uso diagnostico in vitro (IVD), si basa sul principio della cartuccia di immunoreazione caratteristica del sistema LUMIPULSE® G. CSF A few drops of insight can lead to an ocean of understanding A communication campaign to help doctors and healthcare workers explain to patients and their families the advantages of an early diagnosis of Alzheimer's Disease. Read more eServices eServices - your 24/7 online resource eServices is our online product information and customer service resource. Click here to discover the advantages and sign up today in just a few clicks. Read more HE4 Lumipulse® G HE4 - Diagnostic clarity on gynecological cancer We are the company that brought you CA125 and we now introduce HE4, the first new biomarker in 30 years for ovarian cancer management! Read more HE4 & ROMA™ HE4 & ROMA™ What you need to know about HE4 & Roma™ for improved management of ovarian malignancy. Read more HPV The power of HPV genotyping We are one of the world leaders in strip-based diagnostic solutions. Discover our new INNO-LiPA® HPV Genotyping Extra II assay based on SPF10 Plus. Read more HPV Genotyping The power of HPV genotyping We are one of the world leaders in strip-based solutions. Discover our INNO-LiPA® HPV Genotyping Extra assay based on SPF10. Read more LUMIPULSE® G1200 Discover the LUMIPULSE® G1200! Our solid, mid-sized and fully automated CLEIA system is getting installed in laboratories across Europe. Read more about the characteristics of the LUMIPULSE G1200. Read more LUMIPULSE® G600 II Discover the LUMIPULSE® G600 II benchtop analyzer Our new CLEIA system, the LUMIPULSE® G600 II, is a compact and robust benchtop analyzer which features a constant throughput of 60 tests per hour. Read more Neurodegeneration Alzheimer testing Read more about our updated range of INNOTEST® biomarkers for Alzheimer testing. Read more PCT Lumipulse® G B•R•A•H•M•S PCT The most sensitive fully automated PCT (Procalcitonin) test is now available for the LUMIPULSE series. Procalcitonin is a biomarker used for the diagnosis of bacterial infection and sepsis. Read more « EuroMedLab 2017 Vitamina D VITAMINA D CSF eServices HE4 HE4 & ROMA™ HPV HPV Genotyping LUMIPULSE® G1200 LUMIPULSE® G600 II Neurodegeneration PCT » More than 50 years of pioneering expertise in IVD We are a global leader in the field of high quality in vitro diagnostics (IVD) testing. We have more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products (our first IVD test was launched in 1966). We have a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states. Our IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions. Our company CLOSE You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below: Select * - Select - Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunesia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Viet Nam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Check this box if you want our website to remember your choice every time you come back. USA redirect popup Welcome to Fujirebio It looks as if you are visiting from the United States. The content of this website is not destined for United States visitors. If you continue your visit you confirm that you understand that not all of the products you will see listed are FDA cleared. FDA cleared products may not be cleared for all indications mentioned on this site. Product claims may differ from country to country based on regulations and approvals. Please contact your country representative for further details. Are you trying to find regulatory documents? Safety Data Sheets Certificates of Analysis CE Declarations of Conformity Assigned Value Sheets IFUs / Package Inserts News 13/10/2017 Fujirebio Europe announces CE marking of the Lumipulse® G CK-MB assay, used to aid in the diagnosis of Acute Myocardial Infarction (AMI) Events 22/10/2017 IFCC 2017 - International Federation of Clinical Chemistry and Laboratory Medicine Durban, South Africa 04/11/2017 ESGO (European Gynaecological Oncology Congress) 2017 Vienna, Austria 13/11/2017 MEDICA 2017 Düsseldorf, Germany 15/11/2017 Laboratorio Clínico Congress Málaga, Spain 20/11/2017 23° Simposio annuale ELAS-Italia LIGAND ASSAY 2017 Bologna, Italy 21/11/2017 SEN Congress (Spanish Society of Neurología) Valencia, Spain Contact us Share this page: FacebookTwitterLinkedinMail Products & services Product browser Quality Regulatory product documents Resource Center Background articles Biomarkers: β-amyloid and tau Biomarker: HBcrAg Biomarker: HE4 Biomarker: KL-6 Biomarker: Mesothelioma Biomarker: Pepsinogen Biomarker: PIVKA-II Support Frequently Asked Questions Regulatory / Quality documents Safety Data Sheets Certificates of Analysis CE Declarations of Conformity Assigned Value Sheets IFUs / Package Inserts Automated Test Procedures ISO and GMP Certificates Order Handling Conditions of sale Fujirebio Europe distributor extranet Careers Why work at Fujirebio? Job offers Spontaneous application News & Events News Events Sign up for our newsletter Contact Let's stay in touch Follow us on LinkedIn Sign up for our newsletter Customer satisfaction survey How to contact us Find your local contact Fujirebio Europe (Belgium) Fujirebio Diagnostics (Sweden) Data Privacy Contact Terms & Conditions Privacy Policy Cookie Policy © Fujirebio